Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Galaxy MedicareNSE:GML -1.78%21 Equity-to-Asset is 0.83 as of Mar. 2026, which is 26% above its 10-year median of 0.66. GuruFocus rates NSE:GML with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 851 Medical Devices & Instruments companies, Galaxy Medicare ranks better than 80.96% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Galaxy Medicare's Total Stockholders Equity for the quarter that ended in Mar. 2026 was ₹403.4 Mil. Galaxy Medicare's Total Assets for the quarter that ended in Mar. 2026 was ₹487.7 Mil.
Therefore, Galaxy Medicare's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.83.
The historical rank and industry rank for Galaxy Medicare's Equity-to-Asset or its related term are showing as below:
NSE:GML'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.54 Med: 0.66 Max: 0.83
Current: 0.83
During the past 5 years, the highest Equity to Asset Ratio of Galaxy Medicare was 0.83. The lowest was 0.54. And the median was 0.66.
NSE:GML's Equity-to-Asset is ranked better than 80.96% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs NSE:GML: 0.83
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Galaxy Medicare Equity-to-Asset Related Terms
Galaxy Medicare Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Galaxy Medicare's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:GML vs ISRG, BDX, RMD: Equity-to-Asset Comparison
For the Medical Instruments & Supplies subindustry, Galaxy Medicare's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Galaxy Medicare Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Galaxy Medicare's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Galaxy Medicare's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Galaxy Medicare's Equity to Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Galaxy Medicare (NSE:GML) has a Equity-to-Asset of 0.83 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Galaxy Medicare and its competitors. This is 26% above median its historical median of 0.66. Over the past decade, Galaxy Medicare's Equity-to-Asset has ranged from 0.54 to 0.83. According to the industry distribution chart, Galaxy Medicare ranks #162 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 19%.
Is Galaxy Medicare's Equity-to-Asset too high?
Galaxy Medicare's current Equity-to-Asset of 0.83 is 26% above median its 10-year median of 0.66. Over the past 10 years, this metric has ranged from a low of 0.54 to a high of 0.83. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. Galaxy Medicare's value of 0.83 is 29.7% above this industry median. Based on the distribution chart, Galaxy Medicare ranks #162 out of 851 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Galaxy Medicare has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Galaxy Medicare's Equity-to-Asset compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Galaxy Medicare ranks #162 out of 851 companies for Equity-to-Asset. This places Galaxy Medicare in the top 19% of its industry — outperforming the majority of peers. The industry median Equity-to-Asset is 0.64. Galaxy Medicare's value of 0.83 is 29.7% above this benchmark. Historically, Galaxy Medicare's own Equity-to-Asset has ranged from 0.54 to 0.83 over the past decade. While the company's 10-year median is 0.66 vs. the industry median of 0.64, Galaxy Medicare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Galaxy Medicare's current Equity-to-Asset of 0.83 is 29.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Galaxy Medicare and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Galaxy Medicare's current Equity-to-Asset is 0.83, which is 26% above median its own 10-year median of 0.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galaxy Medicare stock overvalued right now?
Galaxy Medicare (NSE:GML) has a current Equity-to-Asset of 0.83. The current Equity-to-Asset is 0.83, which is 26% above median its 10-year median of 0.66 and 29.7% above the Medical Devices & Instruments industry median of 0.64. Galaxy Medicare's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Galaxy Medicare (NSE:GML), the current Equity-to-Asset is 0.83 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Galaxy Medicare Ltd is engaged into the manufacturing, trading and exporting of Medical Devices, Plasters of Paris Bandages (POP Bandage) and Other surgical dressings in India. Its business encompass: Manufacturing and Branding of its own products under its flagship brands i.e. POP BAND, POP CAST, G CAST, GYPSOSOFT, GYPSOPLAST, CARETAPE, GYPSOCREPE, CARECREPE, CAREPORE GYPSONET, GYPSOCHLOR, FIXCAN ETC.
21GF Score
Get the complete analysis for NSE:GML
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GML has been successfully added to your 
